Feasibility and Safety Assessment of a Combined Advanced Therapy Medicinal Product Based on A Polymeric Medical Device Combined to Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Hydrogel Mixture for The Treatment of Knee Femoral Cartilage Isolated Lesions

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512977-28-01

Acronym

LAMINA.ONE

Enrollment

Registered

2024-10-09

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with knee femoral cartilage isolated lesions

None listed

Sex/Gender

All

Age

18 Years to 64 Years

France

None listed

Source: EU CTIS · Data processed: Feb 4, 2026